Propanc Biopharma aims to acquire digital asset technology companies whose market capitalization is below their net asset value. This strategy is part of a plan to strengthen the company’s financial position.
The targeted companies are expected to hold substantial assets in Bitcoin and Ethereum, which aligns with Propanc’s goal of diversifying its asset portfolio.
Leave a Reply